Combination of Docetaxel and Recombinant Vaccine Enhances T-Cell Responses and Antitumor Activity: Effects of Docetaxel on Immune Enhancement

por Garnett, Charlie T., Schlom, Jeffrey, Hodge, James W.
Publicado em 2008

Harnessing the unique local immunostimulatory properties of modified vaccinia Ankara (MVA) virus to generate superior tumor-specific immune responses and antitumor activity in a di...

por Hodge, James W., Higgins, Jack, Schlom, Jeffrey
Publicado em 2009

A potential therapy for chordoma via antibody-dependent cell-mediated cytotoxicity (ADCC) employing NK or high affinity NK (haNK) cells in combination with cetuximab

por Fujii, Rika, Schlom, Jeffrey, Hodge, James W.
Publicado no J Neurosurg (2017)

Natural Born Killers: NK Cells in Cancer Therapy

por Franks, S. Elizabeth, Wolfson, Benjamin, Hodge, James W.
Publicado no Cancers (Basel) (2020)

Stay on Target: Reengaging Cancer Vaccines in Combination Immunotherapy

por Wolfson, Benjamin, Franks, S. Elizabeth, Hodge, James W.
Publicado no Vaccines (Basel) (2021)

Consequence of Dose Scheduling of Sunitinib on Host Immune Response Elements and Vaccine Combination Therapy

por Farsaci, Benedetto, Higgins, Jack P., Hodge, James W.
Publicado em 2011

Vaccines based on whole recombinant Saccharomyces cerevisiae cells

por Ardiani, Andressa, Higgins, Jack P., Hodge, James W.
Publicado no FEMS Yeast Res (2010)

Defining the Molecular Signature of Chemotherapy-Mediated Lung Tumor Phenotype Modulation and Increased Susceptibility to T-Cell Killing

por Gameiro, Sofia R., Caballero, Jorge A., Hodge, James W.
Publicado em 2012

Abscopal Regression of Antigen Disparate Tumors by Antigen Cascade After Systemic Tumor Vaccination in Combination with Local Tumor Radiation

por Hodge, James W., Sharp, Hadley J., Gameiro, Sofia R.
Publicado em 2012

Combining radiation and immunotherapy for synergistic antitumor therapy

por Ferrara, Theresa A., Hodge, James W., Gulley, James L.
Publicado em 2009

Combination Regimens of Radiation Therapy and Therapeutic Cancer Vaccines: Mechanisms and Opportunities

por Garnett-Benson, Charlie, Hodge, James W., Gameiro, Sofia R.
Publicado no Semin Radiat Oncol (2015)

Enhancing immune responses to tumor-associated antigens

por Higgins, Jack P., Bernstein, Michael B., Hodge, James W.
Publicado no Cancer Biol Ther (2009)

Vaccines with Enhanced Costimulation Maintain High Avidity Memory CTL

por Yang, Sixun, Hodge, James W., Grosenbach, Douglas W., Schlom, Jeffrey
Publicado em 2005

Synergizing Radiation Therapy and Immunotherapy for Curing Incurable Cancers: Opportunities and Challenges

por Hodge, James W., Guha, Chandan, Neefjes, Jacques, Gulley, James L.
Publicado em 2008

Attacking malignant cells that survive therapy: Exploiting immunogenic modulation

por Hodge, James W, Kwilas, Anna, Ardiani, Andressa, Gameiro, Sofia R
Publicado em 2013

Radiation-induced survival responses promote immunogenic modulation to enhance immunotherapy in combinatorial regimens

por Gameiro, Sofia R, Ardiani, Andressa, Kwilas, Anna, Hodge, James W
Publicado em 2014

INTRODUCTION: Immunobiology of Radiotherapy: New Paradigms

por Ahmed, Mansoor M., Guha, Chandan, Hodge, James W., Jaffee, Elizabeth
Publicado no Radiat Res (2014)

Combination therapy with an OX40L fusion protein and a vaccine targeting the transcription factor twist inhibits metastasis in a murine model of breast cancer

por Malamas, Anthony S., Hammond, Scott A., Schlom, Jeffrey, Hodge, James W.
Publicado no Oncotarget (2017)

Combining radiation, immunotherapy, and antiangiogenesis agents in the management of cancer: the Three Musketeers or just another quixotic combination?

por Kamrava, Mitchell, Bernstein, Michael B., Camphausen, Kevin, Hodge, James W.
Publicado no Mol Biosyst (2009)

Exploiting off-target effects of estrogen deprivation to sensitize estrogen receptor negative breast cancer to immune killing

por Wolfson, Benjamin, Padget, Michelle R, Schlom, Jeffrey, Hodge, James W
Publicado no J Immunother Cancer (2021)